{"product_id":"global-radiopharmaceutical-market-growth-2023-2029","title":"Global Radiopharmaceutical Market Growth 2023-2029","description":"\u003cp\u003eGlobal Radiopharmaceutical Market Growth 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eRadiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.\u003cbr\u003e\nLPI (LP Information)' newest research report, the “Radiopharmaceutical Industry Forecast” looks at past sales and reviews total world Radiopharmaceutical sales in 2022, providing a comprehensive analysis by region and market sector of projected Radiopharmaceutical sales for 2023 through 2029. With Radiopharmaceutical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceutical industry.\u003cbr\u003e\nThis Insight Report provides a comprehensive analysis of the global Radiopharmaceutical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Radiopharmaceutical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Radiopharmaceutical market.\u003cbr\u003e\nThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceutical and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceutical.\u003cbr\u003e\nThe global Radiopharmaceutical market size is projected to grow from US$ 6613.9 million in 2022 to US$ 11560 million in 2029; it is expected to grow at a CAGR of 11560 from 2023 to 2029.\u003cbr\u003e\nThe global Radiopharmaceutical top three manufacturers include the Bracco Imaging, Bayer and Mallinckrodt, with about 47% market shares. North America and Europe is the main consumption places, with a consumption market share nearly 45% and 27%.\u003cbr\u003e\nThis report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical market by product type, application, key manufacturers and key regions and countries.\u003cbr\u003e\nMarket Segmentation:\u003cbr\u003e\nSegmentation by type\u003cbr\u003e\n Actinium-225\u003cbr\u003e\n Lutetium-177\u003cbr\u003e\n Radium-223\u003cbr\u003e\n Holmium-166\u003cbr\u003e\n Other\u003cbr\u003e\nSegmentation by application\u003cbr\u003e\n Oncology\u003cbr\u003e\n Cardiology\u003cbr\u003e\n Other\u003cbr\u003e\nThis report also splits the market by region:\u003cbr\u003e\n Americas\u003cbr\u003e\n United States\u003cbr\u003e\n Canada\u003cbr\u003e\n Mexico\u003cbr\u003e\n Brazil\u003cbr\u003e\n APAC\u003cbr\u003e\n China\u003cbr\u003e\n Japan\u003cbr\u003e\n Korea\u003cbr\u003e\n Southeast Asia\u003cbr\u003e\n India\u003cbr\u003e\n Australia\u003cbr\u003e\n Europe\u003cbr\u003e\n Germany\u003cbr\u003e\n France\u003cbr\u003e\n UK\u003cbr\u003e\n Italy\u003cbr\u003e\n Russia\u003cbr\u003e\n Middle East \u0026amp; Africa\u003cbr\u003e\n Egypt\u003cbr\u003e\n South Africa\u003cbr\u003e\n Israel\u003cbr\u003e\n Turkey\u003cbr\u003e\n GCC Countries\u003cbr\u003e\nThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\n Bracco Imaging\u003cbr\u003e\n Bayer\u003cbr\u003e\n Mallinckrodt\u003cbr\u003e\n Nordion\u003cbr\u003e\n Triad Isotopes\u003cbr\u003e\n Lantheus\u003cbr\u003e\n IBA Group\u003cbr\u003e\n GE Healthcare\u003cbr\u003e\n China Isotope \u0026amp; Radiation\u003cbr\u003e\n Jubilant Pharma\u003cbr\u003e\n Eli Lilly\u003cbr\u003e\n Advanced Accelerator Applications\u003cbr\u003e\n SIEMENS\u003cbr\u003e\n Dongcheng\u003cbr\u003e\n Navidea\u003cbr\u003e\nKey Questions Addressed in this Report\u003cbr\u003e\nWhat is the 10-year outlook for the global Radiopharmaceutical market?\u003cbr\u003e\nWhat factors are driving Radiopharmaceutical market growth, globally and by region?\u003cbr\u003e\nWhich technologies are poised for the fastest growth by market and region?\u003cbr\u003e\nHow do Radiopharmaceutical market opportunities vary by end market size?\u003cbr\u003e\nHow does Radiopharmaceutical break out type, application?\u003cbr\u003e\nWhat are the influences of COVID-19 and Russia-Ukraine war?\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 115 Pages \/ MCW16234365","offer_id":47650938519858,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-radiopharmaceutical-market-growth-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}